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ABSTRACT 
Diabetic cardiovascular autonomic neuropathy (DCAN) is common in patients with 
diabetes mellitus, and causes abnormalities in heart rate control as well as central and 
peripheral nervous system dynamics. A good understanding of DCAN is not established 
yet. An effective way to detect diabetes mellitus at an early stage is still undiscovered, 
and is highly desired by researchers and patients. One reason why the pathogenesis of 
DCAN is unclear is that non-invasive assessment of DCAN in humans and animals has 
been problematic. The non-stationary and non-linear natures of the interested 
physiological signals have placed great limitation on traditional algorithms. To overcome 
this limitation, this work proposes a series of time-varying, nonlinear and non-invasive 
methods to assess cardiac autonomic dysregulation from ECG and PPG records. 
Including a non-stationary method called PDM, which is based on principal dynamic 
mode (PDM) analysis of heart rate variability (HRV), nonstationary power spectral 
density called TVOPS-VFCDM and also standard spectrum analysis method of HRV. We 
are also able to study and analyze a series of long term and short term ECG and PPG data. 
In a pilot study, ECG was measured via telemetry in conscious 4 month old C57/Bl6 
controls and in Akita mice, a model of insulin-dependent type I diabetes, while PPG was 
measured via tail pulse oximetry from 2 month old to 4 month old. The results indicate 
significant cardiac autonomic impairment in the diabetic mice in comparison to the 
controls at 4 month old and such impairment start to present at 3 month old. Further, 
both immunohistochemistry and Western blot analyses show a reduction in nerve 
density in Akita mice as compared to the control mice, thus, corroborating our data 
analysis records.  
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TERMS AND ABBREVIATIONS 
 
DCAN – Diabetic cardiac autonomic neuropathy 
CAN – Cardiac autonomic neuropathy 
ECG – Electrocardiography  
PPG – Photoplethysmograph  
HR(V) – Heart rate (variability)  
PSD – Power spectrum density 
LF – Low frequency 
HF – High frequency 
RR – R peak to R peak interval 
SDNN – Standard deviation of all normal RR intervals 
RMSSD – Root of the mean squared difference of successive RR 
PDM – Principal dynamic mode 
ANS – Autonomic nervous system 
SNS – Sympathetic nervous system 
PNS – Parasympathetic nervous system 
TVOPS – Time varying optimum parameter search 
VFCDM – Variable frequency complex demodulation  
TH – Tyrosine hydroxylase  
Chat – Choline acetyltransferase 
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SPECIFIC AIMS AND HYPOTHESIS 
Diabetic cardiovascular autonomic neuropathy (DCAN) is one of the most common 
complications in patients with diabetes mellitus, and causes abnormalities in the heart 
rate control as well as the central and peripheral vascular dynamics. Consequences of 
DCAN include exercise intolerance, intra-operative cardiovascular lability, orthostatic 
hypotension, and myocardial ischemia. Currently there is no cure for either DCAN or 
diabetes mellitus, and for most cases, damaged nerves in DCAN is not reversible. The 
only hope for combating DCAN is to have an early recognition, from which the patients 
can receive a prompt and sufficient medical care to prevent further deterioration of nerve 
damage. Moreover, one recent study has reported that if DCAN is detected early, proper 
treatments can be performed so that further deterioration of nerves can be either 
minimized or reversed (1). Thus, an early and sensitive diagnosis of DCAN is critical. In 
addition, such diagnosis approach should be noninvasive and convenient to patients, 
which will facilitate a long term monitoring because the onset of DCAN in diabetic 
patients is uncertain and highly variable.  To this end, our goal of this work is to develop 
noninvasive computational approaches that can provide an early indication of DCAN 
which will allow doctors to give patients prompt treatments to either mitigate further 
deterioration or reverse nerve damage. 
To date, noninvasive approaches for accurate and early detection of DCAN have not 
yet been established. Lacking effective diagnosis of DCAN precludes proper treatment 
which will ultimately lead to irreversible nerve damage. One of the widely-used 
noninvasive approaches for assessing DCAN involves the analysis of heart rate variability 
(HRV) signals.  Power spectral density (PSD) of HRV signal has been shown to 
approximate both sympathetic and parasympathetic dynamics (2).  However, this 
approach has not gained much credence because it cannot separate the parasympathetic 
and sympathetic activities of the autonomic nervous system, hence, an accurate 
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assessment of the DCAN cannot be obtained. Further, the PSD largely assumes linear 
and time-invariant dynamics of HRV signals, which also negatively impact the detection 
accuracy of DCAN.  
To overcome the above mentioned limitations, this work proposes a series of time-
varying, nonlinear and non-invasive methods to assess cardiac autonomic dysregulation 
directly from HRV data. One such non-linear method, which could be easily applied to 
humans, is based on principal dynamic mode (PDM) analysis of HRV.  The PDM method 
is unique, in that it is able to separate the activities of the parasympathetic and 
sympathetic systems without pharmacological intervention (3). Further, we have 
extended the PDM algorithm so that it can track time-varying autonomic nervous 
system’s dynamics. Another technique called modified complex demodulation was 
employed to investigate time progression of HRV spectrum. This method obtains high 
time- and frequency resolutions, which facilitate tracking of not only the dynamics of 
HRV but also, time instant when the ANS activities do occur.  
By utilizing these algorithms, we are able to study and analyze a series of both long-
term and short-term HRV data. In this study, HRV was acquired from two sources: 1. A 
telemetry system which provides continuous long-term ECG recordings from conscious 4 
month old C57/Bl6 controls and Akita mice, which is a model of insulin-dependent type 
I diabetes; 2. A mouse tail-cuff pulse oximeter is used to measure Photoplethysmograph 
(PPG) signal in real time from both conscious 2  - 4 month old C57/Bl6 controls and 
Akita mice to examine if detection of early onset of DCAN is possible using our data 
analysis techniques. We performed both immunohistochemistry and Western blot 
analyses to detect nerve-specific proteins, and compared them against our data analyses 
techniques.   
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The main hypothesis underlying this work is that the development of diabetic 
cardiac autonomic neuropathy (DCAN) can be detected and monitored via evaluation of 
the PDM method which has been shown to provide accurate assessment of the 
autonomic nervous system’s dynamics.  
The specific aims of this work are summarized as follows:  
 
1) To develop computational methods and apply a non-invasive measurement 
modality that is suitable for mice applications for calculating cardiac autonomic function. 
Compare this approach to the traditional HRV analysis methods.  
2) To quantify and discern the difference in the autonomic sympathetic and 
parasympathetic dynamics derived from ECG recordings in 4 month old Akita and age 
matched C57BL6 mice using computational methods.  
3)  To compare protein marker expression that is indicative of the sympathetic and 
parasympathetic nervous systems between Akita and C57BL6 mice. Such comparison is 
used to support our results from the computational methods.  
4) To detect and monitor the progression of DCAN starting from 2 month old to 4 
months in Akita mice using PPG as a measurement modality followed by data analysis 
using the computational methods, and corroborate the results with protein marker for 
autonomic nerves.   
ECG (4 month old mice only) and PPG (from 2-4 month old mice) data were 
collected via ECG telemetry system and tail-cuff PPG sensor, respectively, to derive HRV 
signal. We used PDM to separate the sympathetic and parasympathetic dynamics from 
HRV. To determine protein expression, Tyrosine Hydroxylase (TH) and Choactase 
(Chat), markers of the sympathetic and parasympathetic nerves, respectively, were 
evaluated. These protein marker results were compared to the computational 
approaches performed on HRV data to corroboratetheir accuracy. Furthermore, we 
examined the data length requirement and the sensitivity of the PDM method.  Further, 
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we applied the PDM to determine if the method is sensitive in detecting the onset of the 
impairment in the sympathetic and parasympathetic activities in diabetic mice.  
11 
 
BACKGROUND AND SIGNIFICANCE  
A. Diabetes mellitus  
Diabetes mellitus is a common disease especially in the United States. According to 
data from the 2011 National Diabetes Fact Sheet, there are 23.6 million children and 
adults in the United States with diabetes, and over 79 million Americans have 
prediabetes (early type II diabetes).  About one third of them (7 million people) are 
undiagnosed. The diabetic population with people aged over 20 years is increasing at 1.9 
million per year. Diabetes is categorized into either type I or type II.  Type I diabetes 
mellitus is characterized by the loss of the insulin-producing beta cells of the islets of 
Langerhans in the pancreas, leading to insulin deficiency. This type of diabetes can be 
further classified as immune-mediated or idiopathic.  The majority of type I diabetes is of 
the immune-mediated nature, where beta cell loss is a T-
cell mediated autoimmune attack. Currently there is no cure or prevention for type I 
diabetes which causes approximately 10% of diabetes mellitus cases in North America 
and Europe. Type II diabetes is characterized by insulin resistance which is the defective 
responsiveness of body tissues to insulin. The common outcome of either type I or type 
II diabetes is the abnormal blood glucose level. It is the complications caused by this 
abnormal condition that leads to serious health problems. 
Patients with diabetes mellitus often suffer from blurred vision, fatigue, and 
increased urination at the initial stage, and gradually progress into severe complications 
such as kidney failure, cardiovascular disease and diabetic neuropathy to name a few (4-
7).  Among all diabetic complications, neuropathy is unfortunately the most severe and 
pressing problem as the early detection of nerve degeneration is hard to diagnose.  Nerve 
cells and their supporting blood vessel cells are most vulnerable to high blood glucose 
because none of them are insulin independent for glucose transportation. Excessive 
internal glucose in the cell results in oxidative stress and cell death. The death of 
12 
 
supporting blood vessel cells also accelerates the death of nerve cells. Consequently, over 
60% of diabetes patients are affected by diabetic neuropathy.  
 
 
Figure 1. Illustration of nerve and blood vessel cells damaged due to diabetes 
 
 
B. Diabetic Cardiac Autonomic Neuropathy (DCAN)  
The heart is an essential organ that is highly innervated by the autonomic nerves, 
which are responsible for maintaining cardiovascular homeostasis.  A neuropathy in the 
heart is called DCAN.  DCAN is one of the most overlooked of all serious complications 
of diabetes, and can cause abnormalities in the heart rate control as well as the central 
and peripheral vascular dynamics (8). Consequences of DCAN include exercise 
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intolerance, intraoperative cardiovascular lability, orthostatic hypotension, myocardial 
ischemia, increased risk of mortality, morbidity, and reduced quality of life for people 
with diabetes. All of these symptoms are manifestations of the autonomic neuropathy (8, 
9).  As previously described, this complication is currently not curable and not reversible 
after significant neuronal loss, thus, early diagnosis of DCAN is critical.  For human 
applications, clearly an early diagnosis technique needs to be based on noninvasive 
measurements, be sensitive, accurate and easy to use. One useful noninvasive method to 
assess the autonomic function in various physiological and pathophysiological 
conditions, including evaluation of the autonomic dysfunction in diabetic subjects(10), is 
via the use of heart rate variability (HRV) time series.  It has been shown that the power 
spectral density calculations of HRV provides an approximation of the sympathetic and 
parasympathetic (vagal) influences on the modulation of heart rate (11).  Interactions 
between the sympathetic and parasympathetic nervous activities are essential in the 
regulation of cardiovascular function. The autonomic imbalance, such as sympathetic 
hyperactivity, promotes life-threatening ventricular tachyarrhythmia, whereas 
augmented vagal tone exerts a protective and anti-fibrillatory effect (2). Experimental 
evidence suggests that myocardial ischemia, acute myocardial infarction, sudden cardiac 
death, and chronic heart failure are associated with some degree of the autonomic 
imbalance (9). Further, patients who have had a myocardial infarction (MI) have a 
marked decrease in HRV due to an increase in the sympathetic and a decrease in vagal 
neural activities (9, 12). Reduced HRV is known to be one of the earliest indicators of 
DCAN (13) as it has been shown to involve an imbalance of the autonomic nervous 
system (ANS) (8, 10). A recent study examining the effect of sustained hyperinsulinemic 
hypoglycemia on the cardiovascular autonomic regulation in type I diabetic and their 
non-diabetic counterparts has found a reduced cardiac vagal outflow in these patients 
(10). Another study, examining HRV changes in diabetes, has found that decreases in the 
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autonomic function is present early in the development of diabetes and that the disease 
leads to a progressive decline in the autonomic function (14). These above noted findings 
suggest that HRV can be used as a potential noninvasive indicator of DCAN provided 
that accurate assessment of the sympathetic and parasympathetic dynamics can be 
estimated from the HRV signal. 
 
C. Diabetic animal models  
Diabetic animal models are used to test the efficacy of our analysis techniques.  Further, 
validation of the computational methods will require animal models since both 
immunohistochemistry and Western blot analysis necessitate sacrifice of mice hearts.       
There have been many different animal models to study DCAN.  For example, young 
adult rats treated with streptozotocin (STZ) developed diabetes with significant 
reductions in both the heart rate and HRV, suggesting disturbance in the ANS balance 
(15).  In addition, there were significant reductions in the spectral power at higher 
frequencies, suggesting that the parasympathetic drive to the heart may be altered 
during the early stages of STZ-induced diabetes (15).  Longer duration telemetric 
recordings used to assess the effect of STZ-induced diabetes demonstrated similar 
altered autonomic activities (both sympathetic and parasympathetic) commencing at 4 
weeks followed by similar continuous depressed autonomic activities even up to duration 
of 22 weeks (15). Insulin treatment of these STZ-treated diabetic rats showed no 
significant recovery of the autonomic nervous activity even though heart rate recovered 
to the pre-STZ treated state (16). This suggests that heart rate itself is not a reliable 
diagnostic marker of DCAN (6). The literature on diabetic complications subsequently 
leading to DCAN symptoms in mice is sparse. However, there has been much 
sophisticated work done on peripheral neuropathy complications using various mouse 
models (1, 7, 17). An elegant mouse strain without the confounding effects of toxic 
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chemicals, such as STZ, has been recently introduced and is known as the Tsumuar, 
Suzuki, Obese Diabetes (TSOD) mouse (type II diabetes). The common traits of these 
male mice are glucosurea, hyperglycemia, and hyperinsulinemia (18). The TSOD mouse, 
which is an inbred strain with spontaneous development of diabetes, displays evidence of 
peripheral neuropathy (18). The mice manifest focal swelling of the myelin sheath in the 
sciatic nerve, and accumulation of AGE-modified proteins in the endothelial cells of vasa 
nervorum. Furthermore, the nociceptive threshold for pain was significantly lower in 
TSOD mice (7).  
Another intriguing mouse model of Type I diabetes is the Akita mouse. Ins2C96Y Akita 
mice, which spontaneously develop insulin-dependent diabetes at about 4 weeks of age, 
express a mutant non-functional insulin isoform (17). Recent studies found that Akita 
mice exhibit significant increase in fasting blood glucose levels, gait disturbances, and 
sensory neuropathy (nerve conduction slowing) as early as at 4 months of age (17).  To 
date, research studies detailing the presence and severity of DCAN in Akita mice is scant.  
Recently, a study using the power spectral analysis has found reduced cardiac efficiency, 
contractibility and decreased heart rate and heart rate variability in Akita mice, which all 
imply a possible impairment of the cardiac autonomic regulation (19). 
While in the literature the use of STZ is popular, it has many disadvantages. For 
example, STZ is a toxic chemical which induces diabetes, but it can detrimentally affect 
and alter many vital organs and can lead to other undesired complications (20).  Further, 
STZ-induced mice do not survive more than 5-6 weeks after the onset of diabetes, thus 
evaluation of the progression of DCAN is difficult (21). However, Akita mice are known 
to survive up to 8 months (diabetes onset 3 - 5 weeks of age).  In addition, STZ-induced 
mice and other animal models such as non-obese diabetes (NOD) mice typically exhibit 
less severe hyperglycemia and less dystrophic neuritis over 4 – 5 months; Akita mice is 
known to develop peripheral neuropathy at ~ 4 months (17). Mice model such as TSOD 
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exhibit peripheral neuropathy after 14 months which is also significantly late when 
compared to Akita mice (20). Further, the control strain of Akita mice – C57BL6 
presents very few neuritic dystrophy, thus, Akita mice provide much lower 
complications than some other strains such as the non-diabetic NOD mice (21).  These 
advantages have led us to use Akita mice as a Type I diabetic model for our studies of 
DCAN as you can see in Table I.  
TABLE I 
COMPARISON OF 4 POPULAR MICE MODELS 
 Onset of 
Diabetes 
Life span Severity of 
Neuropathy 
others 
Drug Induced 
(STZ etc.)  
After induction < 5-6 weeks  Less Highly toxic 
Akita 3-5 weeks  8 months Strong - 
NOD 11-30 weeks < 5-6 weeks - - 
Db/db - - Very little - 
 
Akita is an animal model characterized by spontaneous mutant of the insulin 2 gene 
such that it produces an improper folding of the insulin and results in the pancreatic 
beta-cell apoptosis (22). Akita mice start to differ from their control C57BL6 in many 
physiological and metabolic aspects at a relatively early stage. The parameters reflective 
of the severity of diabetes in Akita are shown in Table II (17). 
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Longitudinal blood glucose, body weight and  
peripheral sensory nerve conductivity 
 
 
Figure 2. Glucose and body weight change in Akita mice; peripheral sensory nerve conductivity drop 
noticed at 4 months old 
TABLE II 
ALTERED PHYSIOLOGY PARAMETERS OF AKITA MICE 
  
Data are shown as mean ± SEs. WT, wild type; B2R-null, mice lacking B2R; BRKO, mice lacking both B1R and 
B2R; Akita, mice with heterozygous Akita mutation in Ins2 gene; B2R-null-Akita, B2R-null mice with 
heterozygous Akita mutation in Ins2 gene; BRKO-Akita, BRKO mice with heterozygous Akita mutation in Ins2 
gene; TBARSs, thiobarbituric acid-reactive substances; BP, blood pressure. 
*P < 0.01 vs. the nondiabetic group of the same bradykinin receptor genotype; 
†P < 0.05 vs. the nondiabetic group of the same bradykinin receptor genotype; 
‡P < 0.01 vs. WT (in nondiabetic groups) or Akita (in diabetic groups); 
§P < 0.05 vs. B2R-null (in nondiabetic groups) or B2R-null-Akita (in diabetic groups); 
¶P < 0.05 vs. WT (in nondiabetic groups) or Akita (in diabetic groups). 
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Furthermore, as described above, significant sensory neuropathy (nerve conduction 
slowing) was found in Akita mice starting at 4 month old, as shown in figure 2 (17). This 
study did not report the presence of the autonomic neuropathy, however.  Thus, it is not 
clear if DCAN is also present at 4 month old Akita mice.  Further, if DCAN is present at 4 
months, is it possible that DCAN may appear before 4 months?  Thus, two of the main 
objectives of the present work are to determine the presence of DCAN at 4 month and if 
it exists, can we reliably detect it even at an earlier stage of the progression of DCAN in 
Akita mice. 
 
D. Analysis techniques   
To date, the power spectral density (PSD) of HRV has been the method of choice as a 
noninvasive measure of autonomic nervous imbalance in many pathophysiological 
conditions (2), including diabetes in humans (9, 10, 23) and animal models (15, 24).  
Specifically, the ratio of the low frequency (LF) (0.04 to 0.15 Hz) to high frequency (HF) 
(0.15 to 0.5 Hz) power, as obtained from spectral analysis, has been used as a biomarker 
of the sympathetic-vagal balance in various pathophysiological conditions (25, 26). The 
LF and HF bands for mice are scaled approximately 8 times higher than those of humans 
(8) because mice heart rates are ~ 8 time greater than humans. A large LF/HF ratio 
suggests dominant sympathetic control, whereas a small LF/HF ratio indicates 
predominant vagal control. However, the utility of the LF/HF ratio for clinical use has 
not gained a wide acceptance, mainly because it is an approximation of the autonomic 
balance and does not truly reflect the balance of the two autonomic nervous systems’ 
influences. This shortcoming stems from the fact that the LF/HF ratio assumes that the 
LF is solely mediated by the sympathetic nervous system, despite the prevailing findings 
that the LF reflects both the sympathetic and parasympathetic nervous systems (3).  
Another deficiency of the LF/HF ratio is that the PSD is a linear method, thus, does not 
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properly account for the nonlinear characteristics of the autonomic nervous system. 
Many recent studies have shown that the physiological mechanisms responsible for HRV 
dynamics have significant nonlinear components (2, 23, 27, 28).  While the LF/HF ratio 
obtained via the power spectral density (PSD) is inaccurate, it has paved a way towards 
developing more accurate non-invasive approaches for determining the dynamics of the 
ANS.   
To overcome the limitations of the PSD, many different computational approaches 
have been proposed to separate dynamics of the autonomic nervous system (3).  Of a 
noteworthy technique is known as the Principal Dynamic Mode (PDM), as it has been 
shown to provide accurate separation of the sympathetic and parasympathetic dynamics 
directly from HRV data (3). The accuracy of the PDM partly is due to the fact that it 
specifically accounts for nonlinear dynamics of heart rate control, which the PSD does 
not. The PDM is based on a technique that, among many possible choices of basis 
functions, it isolates only the minimum number of basis functions that correspond to the 
essential dynamics of the nonlinear system. Recent studies on human subjects have 
demonstrated that the nonlinear PDM algorithm is significantly more accurate than the 
PSD for determining the ANS balance (27, 28).  Our results on telemetry recordings of 
ECG data from Akita mice further demonstrate the accuracy and feasibility of the 
method in separating the dynamics of the two branches of the ANS without any 
pharmacological intervention.   
 
E. Nonstationary Power Spectral Density 
Analyses of mice HRV, based on time-invariant power spectral densities, do not 
capture dynamics that change with time. A consequence of this is that subtle changes in 
dynamics are likely to be missed. To account for nonstationary dynamics in the HRV, we 
utilize one of the highest possible time- and frequency-resolution spectral methods to 
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discern and quantify the progression of HRV dynamics during the development of DCAN. 
The technique is known as the modified complex demodulation method (29). It is a 
general purpose time-varying spectral method that can be used to understand dynamic 
characteristics of various biological systems, and offers more accuracy than any other 
method to date, because it provides one of the highest time and frequency resolutions. 
The importance of obtaining one of the highest time and frequency resolutions is that it 
allows us to track not only the transient dynamics inherent in physiological signals at 
each time instant, but also subtle changes that may occur in the dynamics in response to 
various stimuli. Note that the time-varying progression of dynamic information is 
completely lost with the traditional power spectrum, as it is based on a time-invariant 
assumption.  The results section of the Specific Aim 1 briefly highlights the advantages of 
our time-varying spectral method (29). This time-varying PSD is primarily used as a 
guide for examining time-varying frequency contents in the LF and HF bands, and is 
especially appropriate for analyzing long-term telemetry recordings of HRV data. In 
addition, it is used to verify that the major spectral and time components identified by 
the proposed nonlinear time-varying PDM method are consistent with the corresponding 
linear time-varying spectra. 
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Specific Aim 1: To develop a computational, non-invasive method that is 
suitable for mice applications for calculating cardiac autonomic function. 
Compare this approach to the traditional HRV analysis methods. 
Heart rate (HR) is predominantly mediated by the autonomic nervous systems – 
sympathetic system and parasympathetic system; where the sympathetic system elevates 
heart rate and the parasympathetic system depresses the heart rate. This knowledge has 
enabled us to study the autonomic function via noninvasive heart rate variability (HRV) 
analysis. 
Traditionally, the power spectral density (PSD) of HRV has been used as a 
noninvasive measure of autonomic nervous imbalance in many pathophysiological 
conditions (2), including diabetes in both humans (10) and animal models (15, 24). 
Specifically, the ratio of the low frequency (LF) (0.04-0.15 Hz for human & 0.4-1 Hz for 
mice) to high frequency (HF) (0.15-0.5 Hz for human & 1-4 Hz for mice) power obtained 
from spectral analysis has been used as a biomarker of the sympathetic-vagal balance in 
assessing HRV (25). A large LF/HF ratio suggests predominantly sympathetic control, 
whereas a small LF/HF ratio indicates predominantly vagal control. However, the 
LF/HF ratio for clinical use has not gained wide acceptance, mainly because it is an 
approximation of the autonomic balance and does not truly reflect the balance of the two 
nervous influences. This shortcoming stems from the fact that the LF/HF ratio assumes 
the LF is mediated by the sympathetic nervous system, despite the prevailing 
understanding that the LF reflects both the sympathetic and parasympathetic nervous 
systems. 
To combat the limitations of traditional approaches, a new nonlinear, time-invariant 
method that is able to separate the dynamics of the sympathetic and parasympathetic 
nervous systems has been employed. This new technique, known as the Principal 
Dynamic Mode (PDM), provides a more in-depth analysis of the ANS and offers a more 
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accurate measure of the autonomic balance. The method not only specifically accounts 
for the inherent nonlinear dynamics of heart rate control, but also isolates the 
sympathetic and parasympathetic innervations. This advantage allows us to examine and 
describe the true autonomic balance more accurately.  
In addition to nonlinearity, most physiological signals’ dynamics are nonstationary. 
As a result, the HRV analysis based on time-invariant power spectral densities (PSD) do 
not capture dynamics that change with time. This could lead to masking of the 
differences in the ANS dynamics between DCAN and the healthy conditions. Thus, it is 
important to have a tool to capture the temporal variation of the ANS dynamics. More 
importantly, since our telemetry data collection duration lasts a month (24/7), the 
amount of data collected and to be analyzed is large and certainly daunting. Thus, an 
effective time-varying method is needed to determine and analyze only those portions of 
data that are deemed to be stationary. These limitations and demands have motivated us 
to develop a time-varying method that could account for nonstationary dynamics in ECG 
data. A technique that can capture nonstationary dynamics is known as the variable 
complex demodulation method (29). It is a general purpose time-varying spectral 
method that can be used to understand dynamic characteristics of various biological 
systems, and it offers more insights than any other method to date, because it provides 
one of the highest time and frequency resolutions. The importance of obtaining high 
time and frequency resolution is that it allows us to track not only the transient dynamics 
inherent in physiological signals at each time instant, but also subtle changes that may 
occur in the dynamics in response to various stimuli. The results section highlights the 
advantages of our time-varying spectral method. This time-varying PSD was primarily 
used as a guide for examining time-varying frequency content in the LF and HF bands 
and was especially appropriate for long-term telemetry recordings of ECG data. 
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In this task we developed the advanced analysis technique including the PDM 
method and nonstationary power spectrum especially suited for mice. These techniques 
are tested on a short term telemetry ECG testing data to evaluate their performances. 
They are also compared to traditional “gold standard” time- and frequency-domain 
methods as they have all been recommended as the standard parameters for evaluating 
DCAN (2).  
 
Method 
HRV Analysis using PDM 
In order to separate the activities of sympathetic and parasympathetic systems, we 
developed a nonlinear method called PDM. The PDM method, originally introduced by 
Marmarelis, is a method based on extracting only the principal dynamic components of 
the signal via eigenvalue decomposition (30). The PDMs are calculated using Volterra-
Wiener kernels based on expansion of Laguerre polynomials. The application of PDM in 
HRV analysis was introduced in our previous publication (3) thus were not involved in 
this paper. Its main idea is described in detail in the following paragraphs. The general 
input-output relation of a stable nonlinear time-invariant system can be given by the 
Volterra series as following: 
1 2
1 1 1
0 1 2 1 2 1 2
0 0 0
( ) ( ) ( , ) ( ) ( )
M M M
m m m
y n k K x n m k m m x n m x n m
  
  
          
where ( )x n  is the input and  y n is the output of the system. M is the memory of the 
system, which is set as 60 in this study. ki denotes the Volterra kernels, and the quadratic 
kernel k2 describes the nonlinearity of the system. The estimated output with a 
maximum lag M can be expressed in a matrix form: 
( ) ( ) ( )Ty n X n QX n  
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where T denotes transpose, the vector         1, , 1 , , 1TX n x n x n x n M       is 
composed of the input M-point epoch at each time n and a constant 1 that allows 
incorporation of the lower-order kernel contributions, and Q is a    1 1M M  
matrix of Volterra kernels with  
  
[
 
 
 
 
 
 
 
                
 
 
             
 
 
     
 
 
                                   
 
 
                                   
 
 
 
       
         
         
   
 
 
                                     ]
 
 
 
 
 
 
 
 
 
Then these kernels can be expanded based on L Laguerre functions: 
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and [bj(m)] are the Laguerre functions calculated with Laguerre coefficients α=0.5. The 
number of Laguerre functions L is 8 which is decided by mean-square error criterion. 
Then Q can be constructed with the estimated kernels (c0, c1, c2) in following way: 
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where 
0 1 1[    ]
T T T
LB b b b  Laguerre functions are chosen as an appropriate orthonormal 
basis because they exhibit exponential decaying properties that make them suitable for 
physiological systems modeling. In addition, due to basis function expansion, the 
estimation accuracy is maintained even with a small data length.  
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Since 
2c  is a real symmetric square matrix, it can always be decomposed: 2
Tc R R 
where the eigenvector matrix R is always an orthonormal matrix, and Λ is the diagonal 
eigenvalue matrix. The second order kernels are solved by 
T TB R , and Λ reveals the 
relative importance of each kernel. We select only the significant kernels based on 
eigenvalues, as the principal dynamic modes of the system.   
The above algorithm theoretically requires white noise as the input to a system. 
Because only single HR data are available and the real input to a physiological system 
cannot be as irregular as white noise, a broadband input signal is constructed from the 
original heart rate series. We first use a time-varying autoregressive model to track the 
original HR data, then the residual between the estimated signal and original signal is 
taken as the input of the PDM method. The parameters of the model are estimated by the 
method of time-varying optimal parameter search (TVOPS) (31), which ensures the 
performance of tracking. Other tracking techniques also can be used, such as least mean 
square and time-invariant autoregressive model. 
Once the PDMs of HR are obtained from the constructed input, since ANS plays a 
main role in HR regulation, the two most dominant PDMs in HR usually characterize the 
dynamics of the parasympathetic and sympathetic nervous regulations respectively. 
Other eigenvectors are rejected since they may be related to noise or nonessential 
dynamics. More important, dynamics of sympathetic and parasympathetic systems are 
separately represented by two dominant PDMs, thus the problem of PSD method is 
avoided. These two PDMs were converted into frequency domain by FFT to quantify the 
strength of PDMs by power spectrum. The PDM representing the sympathetic system 
has its dominant peak in the LF band of HRV, and henceforth it is termed the LF PDM. 
The PDM of the parasympathetic system contains frequency components from both LF 
and HF ranges, because the parasympathetic activity within LF range is also captured by 
this PDM. With its majority power in the HF range, this PDM is termed the HF PDM.  
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MSE of PDM method using HRV derived from ECG 
                                         C57/BL6                                                                               Akita 
  
 
 
Figure 3 MSE of PDM methods with different number of Laguerre functions and Legendre functions.  
Results are based on ECG signal 
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Hereafter, we also have a LF/HF ratio of PDM to reveal the balance between two 
nervous systems. 
The number of Laguerre basis functions, L, determines the accuracy of the estimated 
Volterra kernels but care should be used not to over fit by using a large L. The memory 
length, M, should be set to be long enough to characterize the complete dynamics of the 
system. The determination of the number of time varying basis functions (Legendre 
function), W, requires some a priori knowledge of the nonstationarities in a system. In 
general, a larger W is needed to track faster nonstationary dynamics. We have based our 
choice of the appropriate values of L and W on the mean-square error criterion. The 
different combination of Legendre and Laguerre function is presented in figure 3. We 
have systematically determined the minimum data record length needed to obtain 
reliable estimates. Sixty seconds of data recording is used and this data length is 
determined by the PDM requirement. This initial minimum amount of data is needed for 
the method to learn and minimize errors to insure accurate tracking of time-variant 
dynamics. 
 
Nonstationary Power Spectral Density 
Analyses of mice ECG data, based on time-invariant power spectral densities, do not 
capture dynamics that change with time. A consequence of this is that subtle changes in 
dynamics are likely to be missed. To account for nonstationary dynamics in the ECG data, 
we have utilized one of the highest possible time- and frequency-resolution spectral 
methods to discern and quantify the progression of HRV dynamics during the 
development of DCAN. The technique is known as variable frequency 
complex demodulation (VFCDM), which was recently developed (29). The details of 
VFCDM method is well documented in (29), thus, are not included here.  
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Thirty minutes of HRV data segments from both Akita and C57/BL6 were used to 
test the VFCDM method as well as PDM method. HRV was calculated from short term 
ECG and each data segment was zero-meaned, and detrended. Since animals present 
different ANS activities in resting state versus active state, we also selected day time 
segment and night time segment from both strain to compare the ANS function under 
different states. 
 
 
Results 
A.  Comparison of PDM Analysis to Traditional Method. 
We tested the ability of PDM to separate the dynamics of the autonomic nervous 
system on 24-hour telemetric recordings of mice heart rate data. The ECG data were 
collected continuously 24 hours per day for 5 days. Data recording commenced 1 week 
after the transmitter device was surgically implanted in sex- and age-matched mice: two 
C57/B16 control mouse and two Akita mice. For the results presented, we chose arbitrary 
5 h segments representing day and night on the 5th day of the 24 h ECG data recordings. 
The daytime recording was the segment from 11 AM to 4 PM and the nighttime recording 
was 11 PM to 4 AM. Each of these 5 h recordings was further segmented into 5 min 
intervals (thus, 60 intervals). The 60 intervals were averaged day- and night-time 
segments.   
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Figure 4. PDMs representing frequency characteristics of the sympathetic (left panels) and parasympathetic 
(right panels) activities during day (top panels) and night (bottom panels). Note that the parasympathetic 
nervous system’s (PNS) dynamic contains significant spectral power in the low frequencies as well as high 
frequencies whereas the sympathetic nervous system (SNS) power is contained only in the low frequency 
ranges.  
The PDM methodology provides two PDM spectra that correspond to the main 
frequency-response characteristics of the two branches of the ANS: sympathetic and 
parasympathetic. The top and bottom panels of figure 4 show frequency responses of the 
two PDMs for the Akita and wild type mouse obtained during day and nighttime, 
respectively; they correspond to the dynamics of the sympathetic (left panels) and 
parasympathetic (right panels) nervous activities. The top left panel has a dominant peak 
centered at ~0.07 Hz, which is in the typical frequency range of the sympathetic nervous 
system. The second PDM (Figure 4: right panels) shows a prominent peak centered at 
~0.07 Hz as well as a secondary peak at 2 Hz. The significance of these two peaks in the 
right panels is that our method correctly identifies the low and high frequency bands that 
the parasympathetic nervous system is known to operate in. Hence, the PDM method 
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allows separation of the two nervous activities that are known to interact nonlinearly. 
More importantly, for both night and day, there are significant reductions in the PDM 
magnitudes associated with parasympathetic and sympathetic nervous activities in the 
Akita mouse (red lines) as compared to the wild type mouse (blue lines). In addition, the 
standard deviation of normal-to-normal (SDNN) beats was markedly reduced in the 
Akita mouse compared to the wild-type mouse. A similar reduction in sympathetic 
amplitudes and reduction in SDNN has also been observed with STZ-treated rats (16, 24, 
32, 33).  
 
Figure 5. PSD representing frequency characteristics of the sympathetic and parasympathetic activities 
during day (top panel) and night (bottom panel) recordings. Note that the low frequency (0.4-1 Hz) regime 
has the activities of both nervous systems, hence, separation of autonomic dynamics is not possible with the 
PSD method. 
 
For comparison, power spectral density (PSD) results from the same wild type and 
Akita mouse are shown in figure 5. Similar to the PDM results, a significant reduction in 
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the spectral power in the Akita mouse is observed for both day- and night-time 
recordings. However, it is unclear whether the low frequency spectral power reduction is 
due to a decrease in the sympathetic or parasympathetic nervous activities since the low 
frequencies (< 0.1 Hz) are attributed to actions of both nervous system activities.  
 
To examine the effect of sympathetic and parasympathetic dynamics on heart rate 
regulation in short term (over 7 days) in a representative Akita mouse, we show in figure 
6, comparison of both the power spectral density and our PDM method. The top panel 
shows heart rate data and the middle panels show both low frequency and high 
frequency power estimated by the power spectral method, respectively. The bottom 
panel shows the separated sympathetic and parasympathetic magnitude using the PDM 
method. Each data point in all panels represents an average of 420 minute data 
segments (~7 hours) obtained during animal’s day time (sleeping or quiet state) 
recordings. As previously described, the power spectrum is not able to separate the 
dynamics of the autonomic nervous system, and it is assumed that the LF and HF are 
predominately mediated by the sympathetic and parasympathetic nervous activities, 
respectively. The power spectral results do not correspond well with the heart rate data 
shown in the top panel. For example, for the first 3 days, the LF increases while the HF 
decreases which, in combination, should result in a higher heart rate, but the opposite is 
seen with the heart rate data shown in the top panel. Similarly, from day 4-6, there is 
increase in HF and a relatively constant LF power, which should result in a net decrease 
in heart rate, but as the top panel shows, we see a small increase in the heart rate. The 
PDM method, shown in the bottom panel, corresponds well with the heart rate data 
shown in the top panel. First, note the greater parasympathetic PDM than the 
sympathetic magnitude as the data were based on day-time recordings (animal’s sleep or 
resting state). With the PDM method, a decrease in heart rate in the first 3 days can be 
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explained by the increase in the parasympathetic activities. Furthermore, an increase in 
the heart rate from days 4-6 can be explained by increase in the sympathetic and 
decrease in the parasympathetic PDM magnitude. Therefore, these results show that the 
PDM method is far more physiologically relevant and accurate than the power spectral 
density approach.  
 
Figure 6. PDM analysis of autonomic balance in a diabetic Akita mouse. HR was measured via telemetry. 
 
B.  Time varying power spectral density  
An underlying assumption in the traditional power spectrum method is signal 
stationarity, i.e., that the frequency components of the signal do not vary with time. As 
most biological signals are time-varying on some scale, the traditional time-invariant 
power spectrum is not generally an appropriate approach in the analysis of ECG signals, 
which do have transient components. For example, suppose you have a signal that 
represents the vertical motion of a point on the wheel of a car over the course of a 
journey. Its frequency of motion would vary depending on whether the car is moving at 
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constant speed, accelerating, decelerating, or at rest. Analysis of this record with 
traditional time-invariant PSD methods would only show the range of frequencies of 
motion achieved over the course of the entire journey, but it fails to provide information 
about the time order in which they occurred.  
 
 
Figure 7. Time-frequency spectra of a wild type (top panels) and an Akita mouse for ~30 min HRV recordings from 
day (left panels) and night (right panels) settings. Note that mice are more active at night. 
To overcome this limitation, we applied a high-resolution approach to estimating 
time-frequency spectra and associated amplitudes and it is termed the time-varying 
optimal parameter search-variable frequency complex demodulation (TVOPS-VFCDM) 
method. Application of the TVOPS-VFCDM time-frequency spectral method to both wild 
type and Akita mouse HRV data (~30 min of recordings during daytime and nighttime) 
is shown in figure 7. There is clearly a greater presence of parasympathetic and 
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sympathetic activities in the wild type than Akita mouse and this difference becomes 
even more pronounced during nighttime. The striking difference that is clearly 
discernable is the lack of high frequency power with the Akita mouse during both night 
and daytime when compared to a wild type mouse. Statistical quantification of these 
time-varying spectral powers can be done using our method. Further, note the transient 
dynamic characteristics of the parasympathetic and sympathetic nervous activities, as 
the frequencies corresponding to them are not constant for all time scales. As a result, we 
cannot neglect the nonstationarity when averaging sympathetic or parasympathetic 
activities, which should be especially concerned when we make comparison between 
Akita and wildtype in the following specific aims. 
 
 
Summary 
 
In this specific aim, we applied a nonlinear PDM method that could uniquely 
separate autonomic functions and a high resolution time-varying spectrum to analyze 
the nonstationarity in the HRV. We compared our PDM method to traditional PSD 
method in quantifying autonomic dynamics and we can conclude that our developed 
nonlinear PDM method is able to successfully capture mice’s cardiac regulation of ANS 
system. In figure 4, we observed that the PDM method extracted two dynamics from 
HRV, named SNS and PNS, had different frequency spectral characteristics. During 
daytime, the detected  sympathetic was elevated while parasympathetic was suppressed 
compare to nighttime, which corresponds to the fact that sympathetic activity decreases 
and parasympathetic increases under sleeping condition, and vice versa for day time.  
This result is similar to some observations using traditional time- and frequency 
approaches (26, 34). However, as we mentioned above, traditional frequency method is 
not accurate enough to quantify sympathetic and parasympathetic activities due to the 
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finding that the former contains only LF components but the latter contains both LF and 
HF components. Note that from figure 4, the parasympathetic activity extracted using 
PDM had a peak power in both LF and HF band, which correctly characterizes the 
parasympathetic dynamics. Meanwhile, the sympathetic dynamics only presents in the 
LF band. Hence this method allows us to accurately describe autonomic balance 
calculations. With this advantage, we can now better quantify individual ANS activities 
and study the impairment of and imbalance of ANS regulations in the following specific 
aims. 
We also tested mice HRV using nonstationary power spectral density-VFCDM, and 
significant nonstationarity was found in all cases. The results indicated that same animal 
has different HRV spectral characteristics in different states (defined as daytime and 
nighttime here); moreover, even at the same state (daytime or nighttime), the 
nonstationarity was still not negligible. This might be due to the fact that when animals 
are at different activity conditions (for example: playing vs. resting), autonomic function 
is certainly altered. If we made a comparison between animals under different states or 
different activity condition, the interpretation would be skewed ( in top-left panel of 
figure 7 for instance, the first 10 minutes of Akita had stronger LF power than last 10 
minutes of WT during daytime). This nonstationary phenomenon implied that in order 
to accurately describe autonomic function as well as to make an unbiased comparison 
between Akita and wildtype, an appropriate data processing strategy is necessary to 
eliminate the time-varying influence. 
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Specific Aim 2: To quantify and discern the difference in the autonomic 
sympathetic and parasympathetic dynamics between Akita and C57BL6 
mice based on ECG using developed computational, non-invasive method. 
It has been found that peripheral neuropathy occurs in Akita mice as early as at the 
age of 4 month old, however, there have been no studies reporting the presence of the 
autonomic neuropathy in this mice model.  As we expect the autonomic neuropathy to 
happen no later than peripheral neuropathy, we are interested in examining whether or 
not DCAN is present in the 4 month old Akita mice using the PDM method.  
The PDM is a computational method which could be applied on HRV series 
calculated from ECG.  We use a telemetry system which records mice ECG via an 
implanted ECG probe. This system enables us to acquire high quality ECG signal and 
perform HRV analysis to evaluate the autonomic function. Although the telemetry 
system is invasive largely to prevent mice from contaminating the sensor, for human use 
in the future, it will rely on noninvasive measuring methods such as a Holter monitor 
device.  Due to a large size and heavy weight of an ECG sensor, we have studied only the 
4 month old mice.  Note that the weight of an ECG sensor is ~5 gms while 4 month old 
Akita mice is on average weights ~25 gms.  Thus, using an ECG sensor on mice that are 
younger than 4 months old mice is not feasible. Also in this study, we were interested in 
examining if there is any further deterioration of DCAN as Akita mice aged.  
As mentioned, the power spectral density (PSD) of HRV has been used as a 
noninvasive measure of the autonomic nervous imbalance in many pathophysiological 
conditions (2), including diabetes in humans (10) and animal models (15, 24).  
Specifically, the ratio of the low frequency (LF) (0.04 to 0.15 Hz) to high frequency (HF) 
(0.15 to 0.5 Hz) power in human subjects, as obtained from spectral analysis, has been 
used as a biomarker of the sympathetic-vagal balance in assessing HRV (25). The LF and 
HF bands for mice are scaled approximately 8 times higher than those of humans (8). A 
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large LF/HF ratio suggests predominantly sympathetic control, whereas a small LF/HF 
ratio indicates predominantly vagal control. However, the LF/HF ratio for clinical use 
has not gained wide acceptance, mainly because it is an approximation of the autonomic 
balance and does not truly reflect the balance of the two nervous influences. 
To combat this limitation, in the previous specific aim we applied an advanced 
nonlinear PDM method that is suitable for mice HRV analysis, and it showed promising 
results in ANS quantification of HRV.  In this task we used the PDM method to 
investigate ANS function of Akita mice and compared it to the traditional time- and 
frequency parameters.  The duration of data recording was 1 ~ 2 months of continuous 
ECG data. 
 
 
Method 
 
Animal surgery and ECG transmitter implantation 
The experiment was performed on 10 age-matched male C57BL/6 (wildtype) and 
Akita mice at 4 month old. All animal-related experimental protocols were approved by 
the Institutional Animal Care and Use Committee at Stony Brook University and 
Worcester Polytechnic Institute. The surgery was conducted in accordance with Division 
of Laboratory Animal Resources (DLAR). Subjects were first anesthetized in a chamber 
with isoflurane and maintained anesthesia with 1% isoflurane in 50% oxygen/50% 
nitrogen on a surgical table. During the whole surgery isoflurane concentration was 
adjusted within a range of 0.8% to 1.5% to keep animal unconscious and to prevent vital 
damage to the animal. The wireless ECG transmitter was then embedded subcutaneously 
in the dorsal part of the animal, and wired electrodes were threaded under skin to reach 
the position of Einthoven bipolar lead II configuration. To maintain fine continuous 
signal recording, the electrodes were sutured to the muscular layer of body wall. Animals 
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were given antibodies immediately after surgery and kept in a warmed cage to recover 
from anesthesia. Further, the animals were allowed one week recovery before we start 
recording of ECG signal. 
 
Telemetry ECG data and mice activities data recording 
Long term ECG and physiological data collection: Wireless subcutaneous (in the 
mid dorsal) ECGs from C57/BL6 control and Akita mice were continuously recorded for 
two months at a sampling rate of 1 KHz via a biotelemetry system (Data Sciences 
International, St. Paul, MN). We recorded the ‘activity’ of each animal via an animal 
activity meter, (Columbus Instruments Inc., Columbus, OH). There are two reasons to 
record activity data: 1. as mentioned in the last specific aim, animals at different activity 
level have significantly different ANS activities (i.e. day time vs. night time). 2. During 
long term recordings, animals are alert thus their movements, body scratching or some 
other activities could induce noise which can significantly impact the quality of the signal. 
Activity recordings were used to help us to characterize segments that are recorded 
during a quiet state so that motion and noise artifacts are minimized. Determination of 
mice’s activity was determined by scanning an infrared beam at 160 Hz.  Each sensor 
beam is spaced every 0.5” (1.27 cm) and total counts of beam interrupted at X, Y and Z 
axes were recorded.  
Data segmentations: Among all these data, we compared the difference between Akita 
and C57 on a weekly basis for duration of 1 month (4 weeks). For each day, we selected a 
15 minutes data segment from animals’ sleeping time and averaged the results based on 
every 1 minute of data analysis. Both heart rate (clean and low) and activity data 
(segments with no activity) were examined to make sure all data segments selected were 
during a quiet condition (figure 8). To ascertain that our choice of data segment is 
representative of all data during quiet state, we also select two other 15 minutes’ 
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segments and analyzed them using the same data analysis protocols. Data were analyzed 
using Matlab r2010a (The Mathworks, Natick, MA) 
 
 
 
 
 
 
 
 
 
 
HRV preprocessing 
R-R interval series were obtained from ECG using our R-wave detection program.  After 
automatic detection of the R-R series- after removing spikes and premature beats, heart 
rates were calculated and down sampled to 10 Hz. Note that HRV was equally spaced via 
the cubic spline procedure as shown in figure 9.  SDNN and RMSSD were calculated 
from the detected R-R intervals. Prior to HRV analysis, all data were detrended, zero-
meaned and normalized to unit variance. 
 
 
 
 
 
 
 
Figure 8 Activity recordings of X,Y, and Z direction, y-axis is the count of object passing a beam  
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Measurement of time and frequency domain parameters 
Time domain parameters including HR (mean heart rate), SDNN (standard deviation 
of normal-to-normal R-R intervals), and RMSSD (root mean square of successive 
differences in normal-to-normal R-R intervals), were calculated from the HRV data. The 
SDNN provides an estimate of overall HRV and the RMSSD yields an estimate of the 
short term components (HF variation) of HRV. In addition, we computed spectral 
powers in the low (LF: 0.4-1 Hz) and high frequencies (HF: 1-4 Hz), and the ratio 
between low and high frequencies (LF/HF) was also calculated. The LF dynamics are 
believed to represent predominantly the sympathetic activities and the HF represents the 
parasympathetic tone, whereas the LF/HF ratio reflects the autonomic balance. The 
Power spectral densities of heart rate data was calculated using the method of the Welch 
periodogram. We computed the PSD every 1 min to ensure that stationary of the data are 
Figure 9 the top left panel presents the original ECG data recorded via Telemetry system; in top right panel, peak 
detection algorithm was used to detect R peaks in ECG and calculate R-R intervals (bottom right). The R-R 
intervals are then converted to heart rate (bottom left). 
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maintained.  All of these “gold standard” indices were calculated according to the 
guidelines of the Task Force of the North American Society of Pacing and 
Electrophysiology (2).  Once we calculate the power spectrum density LF, HF, LF/HF, 
we compared them to the performance of these parameters with the PDM method. 
 
Principle Dynamic Mode  
In specific aim 1, the PDM method was applied to short term mice HRV data 
and the results showed greater sensitivity when compared to PSD approach. The 
task is to analyze telemetry ECG data using PDM. Same data segments as in 
previous section were studied. Since PDM requires a broad band input signal, we 
incorporated TVOPS technique to estimate HRV and use the residual between 
estimated and HRV data as the input. This residual maintains broad band 
characteristics and one advantage is that previous heartbeat in one of the factors 
that influence current heartbeat, thus using this input can better represent the 
actual system.  
Eight Legendre functions were used for TVOPS while 8 Laguerre functions are 
used for PDM. Out of all available PDMs, we selected only the 2 PDMs that have 
the greatest significance as they correspond to the sympathetic and 
parasympathetic characteristics (3). These 2 PDMs were corroborated to 
correspond to the sympathetic and parasympathetic dynamics as shown in Figure 
4.   Once these two dynamics are found, we took ratio between the sympathetic 
and parasympathetic activities to estimate the autonomic balance. 
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Statistical analysis  
For each week, Students t-test was applied to test the difference between Akita and 
wildtype mice, followed by a normality test of Jarque-Bera test. One-way analysis of 
variance (ANOVA) with repeated measurement was used to test among each week. Data 
from three independent data segments were also tested using one-way ANOVA. The null 
hypothesis is rejected when p-value < 0.05.  All statistics were performed using 
SigmaStat 3.0 (SPSS Inc., Chicago, IL) and Matlab (Mathworks, Natick, MA).  
 
RESULTS 
A. Time domain assessment of autonomic function.  
We studied 4 month old age-matched male Wildtype (WT or C57) (n=5) and Akita 
mice (n=5). Four weeks data comparison was presented in figure 10. For each week, data 
was averaged by taking 15 minutes segment every day. We repeatedly selected 3 different 
15 minutes quiet segment according to activity data for every day (represented as in 
figure 10). We found no significant difference between 3 quiet state segments in all 
compared parameters, thus we present results from one arbitrary quiet state segment in 
following figures for simplicity (figure 11 - 13).  
 
Figure 10. Four weeks mean heart rate comparison between WT (n=5) and Akita mice (n=5). There are three 
different data segments selected for each week; * denotes statistical significance at P < 0.05 
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We found consistent and significantly decreased mean heart rate in Akita mice in all 
four weeks, as shown in figure 11.  We also observed reduced SDNN in Akita mice from 
week 1 to week 4 but a statistically significant decrease was observed in only week 3 and 
4. The SDNN parameter is reflective of the overall heart rate variability, thus, a decrease 
of its value indicated reduced ANS regulation in Akita mice. A time-domain parameter, 
RMSSD, shows an increase in Akita mice in weeks 3 and 4.  The RMSSD reflects 
parasympathetic dynamics thus our finding via RMSSD parameter suggests that there is 
higher parasympathetic activities in Akita mice when compared to control mice.   
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Figure 11, 4 weeks mean heart rate, SDNN, and RSSMD, comparison between WT (n=5) and Akita mice 
(n=5). There are three different data segments selected for each week; * denotes statistical significance at P < 
0.05 
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TABLE III 
COMPARISON OF DIFFERENT METHODS FOR HRV ANALYSIS 
 
 
Week 1 Week 2 Week 3 Week 4 
HR Wildtype 505±35 531±21 549±31 530±19 
Akita 421±56 * 417±66* 396±36* 375±26* 
SDNN Wildtype 8.25±1.13 7.96±1.12 8.78±1.61 8.34±1.26 
Akita 6.31±1.94 6.37±0.96 6.26±1.01* 5.88±1.18* 
RMSSD Wildtype 1.66±0.73 1.73±0.39 1.81±0.29 1.94±0.38 
Akita 1.69±0.64 2.01±0.77 2.24±0.21* 2.28±0.30* 
PSD LF Wildtype 3.48±0.18 3.61±0.11 3.62±0.21 3.55±0.22 
Akita 2.97±0.26* 3.07±0.40* 2.93±0.34* 3.05±0.13* 
PSD HF Wildtype 0.73±0.14 0.69±0.14 0.73±0.12 0.76±0.08 
Akita 0.77±0.08 0.92±0.18* 0.99±0.09* 0.97±0.11* 
LF/HF Wildtype 5.99±0.95 6.49±0.55 6.74±1.35 6.12±0.54 
Akita 5.76±0.77 5.15±2.5 4.43±0.80* 4.73±0.39* 
PDM Symp. Wildtype 0.86±0.04 0.86±0.04 0.90±0.06 0.88±0.03 
Akita 0.76±0.06* 0.77±0.07* 0.72±0.05* 0.72±0.06* 
PDM Para. Wildtype 5.04 ±0.49 5.27±0.51 5.07±0.42 4.89±0.35 
Akita 4.26±0.34* 4.19±0.62* 4.38±0.41* 4.27±0.30* 
Symp. 
Para. 
Wildtype 0.21±0.01 0.22±0.03 0.23±0.04 0.24±0.02 
Akita 0.18±0.02* 0.19±0.02* 0.19±0.01* 0.18±0.03* 
           
           Mean ± STD, * denotes for statistical significance (p<0.05); Akita n=5; WT n=5 
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B. Frequency domain (spectral analysis) assessment of autonomic function.  
As shown in top panel of figure 12, the LF power of Akita mice was observed to be 
consistently lower than C57 mice throughout the month, which reflects impaired 
sympathetic innervation. Meanwhile the HF power was significantly higher in Akita mice 
in week 2, 3 and 4; this result is consistent with lower RMSSD values.  This implies 
greater parasympathetic dynamics in Akita mice.  We also estimated the autonomic 
balance by calculating the ratio between LF and HF.  Results shown in figure 13 indicate 
that Akita mice have a much lower LF/HF ratio in comparison to C57 during weeks 3 
and 4.  In addition, we observe that there was no difference of these values among all 
four weeks suggesting that progressive changes in these parameters did not occur.   
 
 
Figure 12. The top panel shows LF and HF power of PSD method; the bottom panel shows the sympathetic 
and parasympathetic dynamics extracted by PDM method; Akita n=5; WT n=5* denotes statistical 
significance at P < 0.05 
 
 
C. PDM analysis of sympathetic and parasympathetic activities.  
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As previously described, the linear frequency domain measures, namely LF, HF band 
and LF/HF ratio, all fail to represent true dynamics of sympathetic, parasympathetic and 
autonomic balance due to the fact that parasympathetic dynamics are present in both LF 
and HF bands.  Consequently, we use PDM because it has been shown to separate 
dynamics of the ANS.  As shown in bottom panel of figure 12, sympathetic and 
parasympathetic activities via PDM (from weeks 1 to 4) are found to be significantly 
reduced in Akita, suggesting depressed or impaired ANS in Akita mice.  Note that 
parasympathetic activities via PDM are lower whereas they were higher with both 
RMSSD and HF power obtained by PSD. This different result obtained by the two 
methods for the parasympathetic can only be ascertained by investigating the actual 
nerves degeneration using gold standard techniques such as immunohistochemistry and 
western blot analysis (see specific aim 3). Again, the Symp/Parasymp ratio clearly 
indicates an autonomic imbalance. Further, it was found that there was no difference in 
our PDM results among all 3 independent data segments suggesting that our choice of a 
data segment is representative of the overall data.  Similar to PSD analysis, we found no 
progression of DCAN during 4 weeks of recordings. 
 
Figure 13. Left panel shows the PSD LF/HF which is the traditional assessment of autonomic balance while 
the right panel show the autonomic balance estimated via PDM method; Akita n=5; WT n=5;  
* denotes statistical significance at P < 0.05 
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Summary 
 
In this specific aim, we have examined the autonomic function via HRV analysis in 4 
month old control and diabetic mice. The present results indicate that we were able to 
detect depressed autonomic function in the type I diabetic mice. First, the mean heart 
rate in Akita mice was 401±56 beats/min which is almost 20% less than the control 
wildtype mice (n=5, p<=0.05) at 4 month old. This reduction has been consistent in the 
following 3 weeks but no further decrease occurred from week 1 to week 4. The time 
domain parameters, SDNN and RMSSD showed some changes in Akita mice. For 
instance, the SDNN had a reduced value in Akita mice while RMSSD showed an 
increased value (only at week 3 and 4). The reduction of SDNN reflects a loss of overall 
heart rate variability while the increased RMSSD reflects elevated high frequency 
oscillations. The three frequency domain parameters also showed similar changes in 
Akita mice where the LF and LF/HF ratio were reduced but HF increased.  
The PDM method by its design is expected to provide more accurate results than 
either the time- or frequency domain counterparts.  It was found that there was a 
reduction in both sympathetic and parasympathetic activities in Akita mice from week 1 
through week 4. Specifically, the normalized sympathetic power decreased from 
0.86±0.04 to 0.73±0.06 (n=5, P<0.05) while the normalized parasympathetic power 
decreased from 5.13±0.49 to 4.39±0.34 (n=5, P<0.05) in week one. Consequently, the 
sympathetic/parasympathetic ratio clearly indicates an autonomic imbalance in Akita 
mice.  Note that both RMSSD and HF PSD showed an increase of parasympathetic 
activities whereas the parasympathetic PDM showed a decrease.  This is certainly a 
contradictory finding and the ground truth can only be verified by examining the 
autonomic nerve density as determined by Western blot and immunohistochemistry 
analysis (see specific aim 3). 
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So far, we successfully established that our PDM method could not only separate 
sympathetic and parasympathetic activities from mice HRV but also detect autonomic 
dysfunction at 4 month old mice.  Since our results are all based on computational 
approaches, it would be important to verify our findings with actual biomarkers of 
autonomic nerve degeneration in mice heart at 4 months old.  Further, another 
important question that needs to be addressed is how early we can noninvasively detect 
the autonomic dysfunction. 
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Specific Aim 3:  To validate our results from computational, non-invasive 
method by comparing protein marker expression that is indicative of the 
sympathetic and parasympathetic nervous systems between Akita and 
C57BL6 mice.  
Based on the findings in Specific Aim 2, a conclusion can be drawn that Akita mice 
have autonomic dysfunctions at the age of four month old. Our HRV analysis using PDM 
approach detected significantly reduced autonomic activity in Akita mice when compared 
to C57/Bl6 mice. To corroborate our noninvasive PDM finding of the significantly 
depressed autonomic dynamics, we performed Western blot immunohistochemistry 
analysis to quantify nerve rarefaction in the SA nodes in both strains of mice, where most 
of the autonomic nerves are located. Certainly, we expect no autonomic nerve rarefaction 
in wildtype but expect it in Akita mice.  It’s well known that nerve cells and the 
supporting blood vessel cells are most vulnerable to excessive blood sugar concentration 
(35). As a result, nerve cells die progressively in diabetes and the loss of supporting blood 
vessels accelerates the process (35). It is reasonable to believe that a reduction of 
autonomic function observed is caused by the death of the autonomic nerves. The next 
question is whether or not there is any noticeable nerve density reduction at 4 month old 
Akita mice. Namely, was the detected autonomic function using our method related to 
the autonomic nerve rarefaction at SA and AV node where cardiac autonomic 
innervation occurs? Assuming such a relationship is established, determining how early 
cardiac autonomic nerve density reduction can be detected becomes extremely 
important because such a time point can be used as an early diagnosis for DCAN via our 
noninvasive method.  It is due to the limitation of current telemetry technology that we 
cannot continually record ECG from mice younger than 4 month but better technology 
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can be expected and eventual facilitate the noninvasive diagnosis at a much earlier time 
frame.  
To achieve the aforementioned goal we need to first corroborate PDM results with 
nerve density via Western blot in mice heart at 4 month old. Once such a relationship is 
obtained, we further examine cardiac autonomic nerve density at 2-3 months old mice. 
Moreover, both protein markers for sympathetic and parasympathetic nerves are tested 
separately. Immunohistochemistry staining is also employed to visualize overall nerve 
distribution. 
 
Method  
Tissue harvesting and preparation  
Three groups of sex- and age-matched (2, 3, and 4 month old) wild-type C57/BL6 (n=5 
for each group)and Akita mice were studied (n= 5 for each group).  
Tissue Collection Mice were euthanized in a CO2 chamber. The heart was rapidly 
excised, and placed into ice-cold phosphate buffered saline (PBS). The atria were 
separated from the ventricles and washed in clean ice-cold PBS three times each to 
remove any blood. Any connective tissue attached to the atria was scraped off. The tissue 
was then moved into a microcentrifuge tube and snap frozen with liquid nitrogen. The 
tissue was stored at -80°C until use.  
Tissue Preparation After thawing of frozen atria tissue on ice, the tissue was placed 
into RIPA Buffer (1 mL, R0278, Sigma-Aldrich), Protease Inhibitor Cocktail (100 μL, 
P2714, Sigma-Aldrich), PMSF (10 μL), and Sodium Orthovanadate (20 μL) (total volume 
of 350 μL was added to each tissue sample). The tissue was diced with a scalpel and kept 
on ice for 1 hour (periodically vortexed). After the lysis, the sample was centrifuged at 
14,000 rpm for 30 minutes at 4°C. The supernatant was then transferred to a new sterile 
tube and frozen at -80°C until use.  
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Western Blot Analysis  
Western blotting of heart tissue (the atrial section of the heart since autonomic nerves 
are more prevalent in the SA and AV nodes) (36) was used to quantify levels of proteins 
of interest in each strain of animals to be utilized. The tissues were homogenized and the 
proteins fractionated according to size in an SDS-polyacrylamide gel and then 
transferred onto a membrane for probing with specific antibodies.  In this study, we 
focused on the proteins tyrosine hydroxylase (37)(TH, a marker for sympathetic nerves), 
synaptophysin (38)(SYN, for general nerves), and choline acetyltransferase (39, 40) 
(ChAT, a marker for parasympathetic nerves). The amount of protein loaded into each 
lane was controlled by determining the total protein concentration by running a 
Bradford Assay for each sample. In addition, the housekeeping protein β-actin was used 
as an internal control. This ensured that the differences we see within protein abundance 
(TH, SYN, and ChAT) represent true differences between each study group and not the 
result of technical artifacts.  
SDS Polyacrylamide Gel Electrophoresis 30 μg protein of each sample was diluted 
with Laemmli Sample Buffer (Bio-Rad) (1:1 dilution), heated at 95°C for 5 minutes, and 
then centrifuged at 14,000 rpm for 1 minute. The samples were loaded onto a freshly 
prepared 10% SDS PAGE adjacent to 5μL of a protein ladder standard (PageRuler, 
Fermentas) and the electrophoresis performed at a constant 115 V (~25 mA) in 
electrophoresis running buffer (25mM Tris, 192mM Glycine, and 0.1% SDS) until the dye 
front reaches the bottom of the gel (~1 hour). At this point, the gel was removed from the 
gel apparatus and rinsed with 1x TBS-T.  
Protein Transfer After gel electrophoresis, the proteins was transferred to a PVDF 
membrane by transverse electrophoresis in a Genie Blotter (Research Products 
International) as described by manufacturer using 25mM Tris, 192 mM Glycine, and 20% 
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Methanol as transfer buffer and 100 V for 1 hour at 4°C. After the transfer, the PVDF 
membrane was removed from the apparatus and washed with 1x TBS-T.  
General Immunoblotting Procedure The membrane was first placed into a blocking 
solution (5% Bio-Rad Blotting Grade Blocker non-fat dry milk, in 1x TBS-T) for 1 hour at 
room temperature to block non-specific protein binding sites. Next, the membrane was 
placed in 1% blocking solution containing the primary antibody (at the dilutions given 
below), overnight, in a cold room. The membrane was then washed 6 times for 15 
minutes each with 1x TBS-T. Afterwards, the membrane was placed into 1% blocking 
solution containing secondary antibody for 1 hour at room temperature, then washed 
again 6 times for 15 minutes each with 1x TBS-T.  
Primary antibodies:  
Tyrosine hydroxylase (TH, for sympathetic nerve): anti-TH, ab112, Abcam Inc. (1:200 
dilutions).  
Synaptophysin (SYP, for general nerves): anti-SYP, sc-9116, Santa Cruz Biotechnology, 
Inc. (1:500 dilution) 
Actin (control): anti-actin, ab50412, Abcam, Inc. (1:5000 dilutions).   
Choactase (for parasympathetic nerve): anti-Choline acetyltransferase, AB144P, 
Millipore Inc. (1:200 dilution).  
Secondary antibodies:  
Anti-rabbit horseradish peroxidase antibody from goat, A6154, Sigma-Aldrich. 
(1:10,000 dilution).  
Membrane Stripping Probed membranes were placed into a stripping buffer (62.5mM 
Tris-HCL, 2% SDS, and 100mM β-mercaptoethanol) at 50°C for 30 minutes, then 
washed 6 times for 5 minutes each with 1x TBS-T. The membrane can then be re-probed 
following the above protocol. 
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Imaging Chemiluminescence solution (Amersham ECLTM Western Blotting Analysis 
System, RPN2109, GE Healthcare) was mixed immediately before imaging. The PVDF 
membrane was soaked in the mixed solution for 1 minute prior to exposure to camera. 
The image of the membrane was obtained by exposure to Chemi Doc camera for 5 
minutes. The ladder image and blotting image was exposed separately and overlaid in 
Photoshop afterwards. 
 
Immunohistochemistry Analysis  
Similar to the Western blot analysis, the immunohistochemistry analysis of 
autonomic innervation in 4 month old mice heart (near either SA node or AV node) 
involved the specific nerve markers (Synaptophysin) for general nerves. The heart was 
snap frozen at -80 C immediately after excised from the animal and sections around SA 
node area were obtained and fixed on Super Frost Slides. Slides fixed in 
paraformaldehydewere then stained with aforementioned three proteins as well as a 
HCN4 antibody (41). The HCN4 is a channel protein only found in SA node therefore it is 
used as a location control for SA node. Stained cardiac sections were examined on a Zeiss 
confocal microscope, and the SA and AV node were assessed to quantify sympathetic and 
parasympathetic innervation. It is well known that SA and AV nodes are densely 
innervated by the autonomic nerves (36).  
 
Data analysis and Statistical analysis  
For each Western blot comparison, the image was inverted and the integrated 
density of each interested protein band was recorded (using Adobe Photoshop CS4, 
Adobe). This density value was divided by the integrated density value of Actin in the 
same well to obtain a normalized value. 
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 Students’ t-test was applied to test the normalized integrated density value between 
Akita and wildtype mice, followed by a normality test of Jarque-Bera test. The null 
hypothesis is rejected when p-value < 0.05.  All statistics were performed using SigmStat 
3.0 (SPSS Inc., Chicago, IL) and Matlab (Mathworks, Natick, MA).  
 
Results 
A). Western blot assessment of autonomic nerves density.  
Our HRV analysis using PDM approach indicates significantly reduced autonomic 
activity in Akita mice when compared to C57/Bl6 mice at the age of 4 month. To 
corroborate our noninvasive PDM approach finding of significantly depressed autonomic 
nervous dynamics, we performed Western blot analysis to quantify nerve rarefaction in 
the SA and AV nodes in both strains of 4 month old mice (n=5). We expect no autonomic 
nerve rarefaction in C57 but certainly expect it in Akita mice. As observed in figure 14 all three 
proteins are less expressed in Akita mice compare to C57, which illustrates a noticeable 
autonomic nerve (both sympathetic and parasympathetic) rarefaction. We recorded the 
integrated density of each bar on the Western blot and Actin was used as a control for 
total protein volume of each lane, thus each calculated density is normalized to the 
density of actin as the final density. In Table IV, we show the normalized density of each 
neural marker, which represents a significant reduction of all autonomic nerve in 4 
months old Akita. This result corroborates our PDM findings in the previous specific aim. 
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Figure 14, western blot of 4 months old Akita (n=5) VS. Wildtype (n=5), the SYN is a marker for general 
nerves, Chat marks parasympathetic nerves and TH marks sympathetic 
 
We also investigated the possibility of autonomic nerve rarefaction on younger mice; 
seeking to potentially diagnose DCAN at an earlier stage using our technique. In figure 15 
we show Western blot of TH, SYN, and Chat antibodies in 3 month old mice (Akita n = 5 
and wildtype n = 5). After normalizing the integrated density to actin, a significant 
reduction was found in Akita mice.  The same experiments were performed on 2 month 
old mice (figure 16, Akita n = 5 and wildtype n = 5), however, there was no noticeable 
reduction. These results indicate an autonomic nerve rarefaction presents as early as 3 
month and such a rarefaction might be detected using our approach, as we did in four 
month old mice.  
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Figure 15, western blot of 3 months old Akita VS. C57, Akita n=5; Wildtype n=5 
 
Figure 16, western blot of 2 months old Akita VS. C57, Akita n =5; Wildtype n=5. 
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TABLE IV 
QUANTIFICATION OF WESTERN BLOT ANALYSIS 
  TH Chat Syn 
4 months  WT 1.52 ± 0.18 0.99 ± 0.27 1.14 ± 0.43 
Akita 1.18± 0.20 * 0.66 ± 0.13 * 0.50 ± 0.15 * 
3 months WT 1.11 ± 0.12 1.06 ± 0.07  
Akita 0.87 ± 0.15 * 0.84 ± 0.02 *  
2 months WT 0.48 ± 0.08 0.65 ± 0.12  
 Akita 0.49 ± 0.05 0.62 ± 0.07  
 
The * denotes statistical significance with P <0.05, WT n=5 and Akita =5 for each age group 
 
B). Immunohistochemical assessment of cardiac autonomic innervations.  
We also performed immunohistochemical staining on the overall neural markers to 
examine if indeed total autonomic nerves are less presented in SA node. A general nerve 
marker (anti-synaptophysin) staining is obtained. Figure 17 shows deconvoluted optical 
sections double stained for HCN4 (red), a membrane channel found only in sinoatrial 
(SA) and atrioventricle (AV) nodes in the heart; the synaptophysin (green) was used to 
stain for general nerves. The negative control was obtained by omitting both primary 
antibodies and the image was not deconvolved.  As shown in figure 17, the SA node in 
this Akita mouse is clearly less densely innervated than the C57 control; a similar 
reduction in nerve density was seen in sections of the AV node in this Akita mouse (not 
shown). This rarefaction corroborates our signal processing results of the reduction of 
sympathetic and parasympathetic functions. 
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Comparison of overall nerve density in 4 month old Akita and age matched 
C57/BL6
 
Figure 17, Immunostaining of SA nodes for HCN4 channels (red) and synaptophysin (green). Images 
are deconvolved optical sections. In the negative control both primary antibodies were omitted, and the 
image was not deconvolved. The sections were stained concurrently & imaged with the same settings. 
All the images were cropped and subjected to 20% contrast enhancement.  
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Summary 
In this aim we examined the presence of nerve degeneration using three nerve 
protein markers: tyrosine hydroxylase (TH, a marker for sympathetic nerves), choline 
acetyltransferase (ChAT, a marker for parasympathetic nerves) and synaptophysin (SYN, 
a marker for general nerves).  Sex- and age-matched wild-type C57 and Akita mice from 
2 month old to 4 month old were compared.  In 4 month old Akita, protein markers was 
found significantly less expressed compared to C57 which corroborated our data analysis 
findings in autonomic function. This result indicated that the observed autonomic 
dysfunction at 4 months old is caused by the autonomic nerves rarefaction; in other 
words, the autonomic rarefaction could be detected using our developed technique in 4 
month old Akita. Although we do not have access to 3 month old mice ECG data, a 
similar reduction of autonomic nerve density was found in 3 month old Akita heart 
which implied that our method had a potential to diagnose the ANS impairment at that 
time point. This needs to be further tested in the future. 
Finally, there was no nerve degeneration observed in 2 month old Akita and this is 
similar to other studies on peripheral neuropathy (21). Note that if ECG can be acquired 
in younger mice, noninvasive HRV analysis can be performed to see if there is a sign of 
autonomic dysfunction before a detectable nerve degeneration occurs. 
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Specific Aim 4: To detect and monitor the progression of DCAN in Akita 
mice based on PPG using our computational, non-invasive method. 
In order to detect and monitor the development of DCAN using our computational 
method, HRV data prior to the onset of DCAN is required.  Data analyses in the Specific 
Aim 2 were performed on HRV series extracted from ECG data on mice that were 4 
month old.  In this aim, we are interested in examining the onset and progression of 
DCAN, thus, requiring us to examine mice that are as young as 2 month old.  However, 
due to Akita’s small weight and a large size of an ECG telemetry sensor, we chose a pulse 
oximeter sensor to collect HRV data.  It has been shown that heart rate variability can be 
effectively measured by pulse oximetry (42). The pulse oximeter measures 
photoplethysmograph (PPG), which reflects the changes in blood oxygenation. Blood 
and tissue have different absorbance to infrared light, thus, each volume change caused 
by heart beat is captured by an infrared receptor (43). Although the PPG reflects 
influences from both heart beat and blood vessel capacity, extensive HRV analysis were 
performed using PPG and it has shown a good correlation to HRV (44). 
One advantage of PPG sensors is that it can be easily attached to animal tails, which 
in turn does not create physiological stress when compared to an implantable ECG 
sensor. For our work, we used a commercially-available mice tail PPG system – 
MouseStat (Kent Scientific Corp.) which allowed us to conduct HRV studies on mice less 
than 4 months old. Data from 10 Sex- and Age- matched mice (Akita n = 5 and Wildtype 
n = 5) were recorded starting from 1.5 month to 4 month old. These data were 
investigated and compared to our previous ECG-based HRV analysis results (when the 
animal reached 4 months). 
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Method 
Data acquisition 
Mice were conscious and restrained in a tube-shaped mouse restrainer with their tails 
exposed. They are then placed on a heating pad and temperature was adjusted as needed. 
The Y-clip PPG sensor is placed on the proximal portion of the tail where appropriate 
humidity is maintained to produce the best signal. Ten minutes settling time was allowed 
so that a mouse can get used to the restrainer and Y-clip prior to the start of data 
recording. PPG Data from 10 Sex- and Age- matched mice (Akita n = 5 and Wildtype n = 
5) were collected for 30 min. ~ 1 hr. each day, 5 days a week. The entire recording 
process lasted 2.5 months (1.5 month old mice to when they reached 4 months).  PPG 
data were recorded at a sampling rate of 600 Hz. 
 
Data processing and analysis 
For each day, a 15 minute data segment that was free from motion and noise artifacts 
were selected and averaged based on every 1 minute of data analysis of the entire 15 
minutes segment. (note that mice were conscious, thus a large part of data would be 
corrupted by motion artifacts). In time domain, to obtain heart beat interval, we develop 
a peak detection program which detected each peak of the PPG wave as shown in figure 
18. The time interval durations were recorded as R-R interval series.  The SDNN and 
RMSSD parameters were calculated from the R-R interval series.  
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In frequency domain, we obtained HRV by converting R-R intervals into beats/min and 
using a cubic splining technique to ensure equal sampling of the HRV data. The HRV 
data were zero-meaned, detrended and down sampled to 10 Hz prior to calculations of 
the PSD and PDM analyses. The number of basis functions for PDM was determined by 
the mean square error (MSE) criteria. The MSE values corresponding to different basis 
function combinations are presented in figure 19.  As shown, 11 Legendre functions with 
8 Laguerre functions were chosen for our analysis since this combination provided the 
smallest MSE value. Statistical analysis  was performed similar to Specific Aim 2 
  
 
Figure 18, example of peak detection for PPG signal recording 
Peak detechion of PPG signal
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MSE of PDM method using HRV derived from PPG 
                                         C57/BL6                                                                          Akita 
  
 
 
Figure 19, MSE of PDM method with different number of Laguerre functions and Legendre functions.  
Results are based on PPG signal 
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Results   
Based on HRV calculated from PPG, we examined the autonomic function via PDM 
method and the traditional time- and frequency parameters.  The PDM results and time- 
and frequency-domain parameters were compared to previous results obtained from 
ECG when appropriate (e.g. at 4 months). 
 
A. Time- and frequency- domain assessment of autonomic function.  
Similar to the Specific Aim 2, the standard time- and frequency-parameters were 
investigated on a weekly basis. Results were recorded from week 6 through week 19, thus, 
14 weeks of data comparison is presented in figure 20. Each data point is the average of 
each week, which consists of 15 minutes a day 5 days a week. We have found a consistent 
and significant decreased mean heart rate in Akita mice starting at week 9, as shown in 
the top panel of figure 20, which indicates an altered autonomic function that begins at 2 
month old Akita mice.  We also observed some non-significant decrease in SDNN value 
in Akita mice after week 12. The SDNN parameter is reflective of the overall heart rate 
variability, and no consistent overall reduction in the autonomic function is observed 
with our data. The RMSSD also did not significantly change in Akita mice during the first 
half of the experiment, but in some weeks, RMSSD values showed a significant reduction. 
However, note that there was an increase in RMSSD values in week 19 in Akita. 
Therefore, results of both the SDNN and RMSSD are scattered and not consistent, 
leading to an inconclusive interpretation. The effectiveness and reliability of these two 
traditional parameters are thus questionable.   
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Figure 20, comparison of mean heart rate, SDNN, and RSSMD between C57  (n=5) and Akita (n=5) mice from 
6 weeks old to 19 weeks old. * denotes statistical significance at P < 0.05 
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B. Frequency domain (spectral analysis) assessment of autonomic function.  
In the frequency domain, LF and HF band spectral powers are used as an indicator of 
the sympathetic and parasympathetic activities. As shown in the top panel of figure 21, 
no significant changes in the normalized LF power were observed in Akita mice 
throughout the experiment (except for week 11) which implies that no sympathetic 
impairment can be found using this method. Meanwhile, the HF power did not change 
initially in Akita followed by a slight reduction on week 10 to week 18 but not in week 15, 
17 and 19. Similar to RMSSD values, the difference between two strains is not consistent 
throughout the experiment. The lower HF power implies lower parasympathetic 
activities but apparently no consistent parasympathetic impairment can be concluded. 
We also estimated the autonomic balance by calculating the ratio between LF and HF.  
Results shown in figure 23 indicate that Akita mice did not have significant change in 
LF/HF ratio in comparison to C57 throughout the experiment.   
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Figure 21, the top panel shows LF and HF power of PSD method; the top and bottom panel show the 
comparison of LF and HF power based on weekly basis; C57 (n=5); Akita n=5. * denotes statistical 
significance at P < 0.05 
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C. PDM analysis of sympathetic and parasympathetic activities.  
As we have confirmed in the Specific Aims 2 and 3, the reduction of the autonomic 
function can be expected in 3 -4 month old Akita mice. However, as shown in the results 
section B, the linear frequency domain measures, namely the LF, HF and LF/HF ratio, 
all failed to discern differences in the sympathetic and parasympathetic dynamics, as 
well as the autonomic balance between Akita and C57, even for those mice that are 4 
month old. This result is contradictory to what we have observed in the Specific Aims 2 
and 3. Therefore, we used PDM because it is a nonlinear and nonstationary method that 
has been shown to provide more accurate characterization of the ANS function.  As 
shown in the bottom panel of figure 22, the PDM-derived sympathetic power remains 
unchanged initially but then decreases from week 11 throughout the experiment in Akita 
mice. Such reduction became greater after the onset of the sympathetic impairment and 
then to the end of the experiment. This result suggests that depressed or impaired 
sympathetic activities are presented as early as 3 months in Akita and become more 
severe as they grow. On the contrary, the parasympathetic power via PDM shows no 
change for all time points.  Note that mice were in an active state thus parasympathetic 
activities were already depressed, thus difference of the parasympathetic activities 
between Akita and C57 will not likely to occur.  The Symp/Parasymp ratio also clearly 
indicates an autonomic imbalance starting at week 11 and then throughout the 
experiment. In this case, the autonomic imbalance in Akita is most likely due to 
decreased sympathetic activities since there was no significant change in the 
parasympathetic dynamics  
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Figure 22, the top and bottom panel shows the sympathetic and parasympathetic dynamics extracted by PDM 
method; C57 (n=5); Akita n=5. * denotes statistical significance at P < 0.05 
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Figure 23, the top and bottom panel shows autonomic balance calculated by LF/HF ratio and PDM 
Sym./Parasym.; C57 (n=5); Akita n=5.  * denotes statistical significance at P < 0.05 
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Summary 
In this specific aim, we have examined the development of the ANS impairment on 
Akita mice from the age of 6 weeks to 19 weeks.  The heart rate of Akita mice decreased 
starting from week 9 and maintained this trend throughout the experiment. The 
abnormal heart rate in Akita mice indicated a possible impaired autonomic function. By 
using the PDM method, we successfully found an impaired sympathetic function starting 
at week 11 and continued to deteriorate until the end of the experiment. However the 
parasympathetic power via PDM did not change most likely due to already depressed 
parasympathetic activities in conscious mice.  Unlike the previous specific aims, the time 
and frequency domain parameters failed to characterize the altered ANS function in 
Akita mice using the pulse oximeter recordings. This observation may also stem from the 
fact that PPG are collected in alert animals and the stress they experienced created 
greater variability and complexity in the signal. It may be more difficult for the 
traditional linear and stationary methods to characterize the autonomic function. 
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DISCUSSION 
 
Diabetic autonomic neuropathy (DAN) is a disease involving the entire autonomic 
nervous system and it is a common complication of diabetes.  Cardiovascular autonomic 
neuropathy is one of the most studied and a clinical subset of DAN.  Timely diagnosis of 
DCAN is needed as individuals with abnormal autonomic function are found to have a 
greater risk for severe hypoglycemia (10).  Diagnosis of DCAN currently involves many 
different autonomic function tests and involves testing of RR variability, Valsalva 
maneuver and postural blood pressure testing. It has been suggested that regular HRV 
testing provides early detection of DCAN which subsequently can lead to timely 
therapeutic interventions (45).  For example, it has been suggested that peripheral 
neuropathy can be reversed if timely detection and appropriate subsequent therapeutic 
interventions (such as inhibition of caspase-mediated pathway) are administered (46).    
To this end, the goal of our present work is to demonstrate an alternative to the 
traditional HRV measures involving both time- and frequency-domain parameters which 
have been well documented to have many shortcomings.  This was the case with our 
results as we found significantly increased parasympathetic dynamics as determined by 
the increased HF power as well as RMSSD values (see Table II) in Akita as compared to 
wildtype mice.  The PDM, on the contrary, showed a significant decrease in the 
parasympathetic dynamics. The gold-standard approaches such as 
immunohistochemistry staining and Western blot analysis of mice heart clearly showed a 
significant decrease in the parasympathetic and sympathetic nerve densities in Akita as 
compared to wildtype mice, corroborating our PDM results.  Thus, our current work 
demonstrates a more effective and sensitive approach to HRV analysis in the diagnosis of 
DCAN than the traditional HRV measures.  The advantage of using PDM method over 
the traditional HRV measures has been already demonstrated in our previous study 
involving healthy subjects with the aid of pharmacological blockades (27).    
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We have primarily studied 4 month old Akita mice because peripheral neuropathy is 
known to occur after mice have reached this age.  Our work suggests DCAN also occurs 
at 4 months old.  However, researchers did not know if DCAN occurs earlier than 4 
months.  The Western Blot analysis implies autonomic dysfunction might occur before 4 
month old such as 3 month old, thus, we are interested in investigating the onset of 
DCAN in Akita mice at younger ages.  The main roadblock to recording telemetry ECG 
earlier than 4 months is that a telemetry sensor is too big and heavy (~5 gms).  Note that 
a 1 month old Akita mouse weighs ~16 gms. To circumvent this limitation, we 
investigated the use of a tail-cuff PPG sensor as our results suggest that accurate RR 
intervals can be obtained in 1 month old mice.  This allows us to monitor the progression 
and onset of DCAN in Akita mice. 
By utilizing a noninvasive PPG sensor we avoided ECG sensor implantation surgeries 
and overcame many technical limitations associated with ECG data collection. In fact we 
were able to obtain signals from Akita mice that were as young as 1 month old. From the 
results, the long term heart rate monitoring suggests that Akita mice start to present 
their abnormal heart rate (lower than wildtype) at about 9 weeks old (2 month). 
Meanwhile, the PDM-derived sympathetic dynamics clearly showed the onset of the 
sympathetic function impairment and autonomic imbalance starting at 11 weeks.  To 
date, the earliest reported diabetic neuropathy in Akita mice was observed at 4 month of 
age. Therefore our technique provides a promising potential for early diagnosis of DCAN.  
Note that the Specific Aim 3 has shown evidence of parasympathetic nerve 
degeneration in Akita mice at 4 months old which was also confirmed with our signal 
processing approach as detailed in the Specific Aim 2.  However, we did not observe 
PDM-derived parasympathetic impairment in the PPG recordings. This conflicting result 
may be due to the different state (alert v. quiet) of mice at which we collected data. 
Under an alert state, which was the condition of these experiments, the parasympathetic 
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activities are far more depressed in both strains of mice. Thus, the difference between 
Akita and C57 is likely to be minimal. In contrast, for the quiet state data, which was 
used in ECG recordings, the parasympathetic system was more enhanced thus, any 
difference will be more pronounced.  
As a computational method, the technique we have developed can be easily 
implementable for clinical applications since ECG or PPG recordings are convenient and 
already widely used. Personal health is becoming more important for both diseased and 
healthy subjects. Our technique, which needs only a few minutes of ECG or PPG 
recordings, can provide an estimate of autonomic function in near real-time. With daily 
monitoring, diabetic patients will be able to keep track of their development of DCAN 
and receive prompt and proper medical care. Therefore this technique will potentially 
allow patients to better control DCAN condition; if detected early, there is a hope that 
DCAN be reversed. 
For future clinical applications to be viable with PDM method for detection of DCAN, 
a threshold value of the ANS dynamics needs to be determined. Further, it is unknown if 
the autonomic function detected by PDM will be sensitive enough to distinguish DCAN 
subject from normal subject for all age groups. Even within the same age group, the 
sensitivity and specificity will require thorough investigation since human subjects have 
more complicated physiological conditions compared to mice. These are some of the 
obstacles that need to be overcome before the PDM can be utilized as a detector of DCAN 
in a clinical setting, or for home care diagnostic usage. 
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CONCLUSION 
In this study, we developed a noninvasive HRV analysis approach suitable for mice 
applications. This approach is able to detect autonomic dysfunction based on HRV 
measurements. We employed this technique and analyzed long term telemetry ECG 
recordings from 4 month old mice to investigate autonomic dysfunction in diabetic mice. 
Traditional method for autonomic function assessment is based on time- and frequency- 
domain parameters of HRV. However, they are problematic mainly due to two reasons: 1. 
inaccuracy in separating the sympathetic and parasympathetic activities; 2. not 
accounting for nonlinearity in HRV signals. Our PDM technique overcomes these 
limitations and its performance was tested against the traditional methods. Our method 
PDM by design, overcome these two limitations and provided more accurate DCAN 
assessment than the conventional approaches. 
ECG was measured via telemetry in conscious sex- and age- matched 4 month old 
C57/Bl6 controls and Akita mice.  Our results indicate a significant cardiac autonomic 
impairment in the diabetic mice.  Further, both immunohistochemical and Western blot 
analyses show a reduction in nerve density in Akita mice as compared to the control mice, 
thus, corroborating our PDM data analysis of HRV records. In order to monitor the long 
term progression of DCAN, the PPG data from 1 month old mice to 4 month old mice 
were also measured. Our method found the onset of the impaired autonomic function in 
Akita mice starting at 3 months. The long-term goal of this project is to develop this 
method to the point at which it can be used to detect DCAN in diabetic subjects. 
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FUTURE WORK 
In Specific Aim 3 we have examined the expression of protein markers for autonomic 
nerves system in 2, 3, and 4 month old mice using Western blot analysis. The difference 
of autonomic nerves density found between Akita and C57BL6 mice corroborates our 
computational findings.,  
In specific aim 3, we only visualized the overall nerve density reduction in 4 month 
old Akita mice using immunohistochemistry staining. The sympathetic and 
parasympathetic nerve densities will be further examined in 2 month, 3 month and 4 
month old mice. This will further validate our computational analysis and Western blot 
results in 2, 3, and 4 month old mice. 
So far, the computational results from conscious young mice (namely 2 and 3 month 
old) are derived only from PPG recordings, when they are in an active state. While the 
animals were in an active state, they were resrained in an immobilizer which can result 
in significant stress to animals.  In other words, stress and fear can elevate the 
sympathetic nervous dynamics.  The motion artifacts which is significant in active 
animals prevented us from obtaining accurate autonomic dynamics using ECG 
recordings. Thus, we had to resort to data analysis for those segments that were deemed 
to be in an inactive state.  The above described scenarios may have resulted in 
contradictory results in the 4 month old mice using ECG and PPG recordings.. As a part 
of future work, One possible solution to overcome the difference seen is to use blood 
pressure recordings as the pressure sensor is applicable to even 2 month oldmice.  Note 
that RR interval can be derived from blood pressure data.   
 As discussed in the previous section, further steps need to be taken before future clinical 
use can be realized. Our technique is noninvasive and only requires a few minutes of ECG, 
contiuous blood pressure or PPG recordings, which makes it easier to satisfy FDA regulations. 
Once approved by FDA, we will need to thoroughly investigate our technique for human 
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applications. Proper threshold of DCAN for human subjects needs to be obtained, which will 
probably be variable for different age groups. Moreover, the sensitivity and specificity also need 
to be established for human subjects.  
There are some other potential applications of our technique.  One such application is to 
use a smart phone to collect RR intervals (47). It has been shown that a video camera that resides 
on a smart phone can be used to capture heart rate fluctuations (47).  Once a proper threshold for 
DCAN is obtained, our technique can be implemented into a smart phone. Diabetic patients will 
be allowed to monitor their development or detection of DCAN at their leisure in their homes by 
taking a few minute of PPG recordings using a smart phone. The convenience and efficiency of 
this technique has the potential to significantly impact the diagnostics of DCAN which has not 
been possible to date.   
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